My Awesome Newsletter

Archives
Log in
Subscribe
June 29, 2026

Medtronic's tariff hit + GLP-1 cold chain boom

Supply Chain Pulse — 2026-06-29

Medtronic's CEO is putting numbers to the tariff pain — and the picture isn't pretty for device-heavy supply chains heading into Q3. At the same time, UPS is dropping $48 million on cold chain infrastructure to chase the GLP-1 wave, a signal that temperature-sensitive drug logistics is becoming a major cost center across the industry. Together, these stories frame a familiar tension: external cost pressures squeezing margins on one side while demand-driven investment reshapes distribution on the other. If you haven't stress-tested your device contract pricing and cold storage capacity lately, today is a good day to start.


Quick Hits

  • Medtronic tariff disclosure also covered by Yahoo Finance — worth tracking across earnings calls as more device makers report similar headwinds this quarter. (Yahoo Finance)

Medtronic CEO Discloses Tariff Impact on the Company

Medtronic CEO Geoff Martha has broken down how current U.S. tariff policy is hitting the medical device giant, which manufactures and sources components across a global footprint spanning Ireland, China, and beyond. For hospital and ASC supply chain leaders, this matters because Medtronic is a top-tier supplier in cardiac, spine, and surgical categories — cost increases at the manufacturer level historically translate into price pressure during contract renewals. Watch your Medtronic agreements closely, and consider where you have flexibility to standardize or dual-source ahead of any announced price adjustments.

Source: Insider Monkey

1 in 8 Americans Now Take GLP-1 Drugs — UPS Is Investing $48M to Keep Them Cold

With 12.5% of Americans now on GLP-1 medications like semaglutide and tirzepatide, UPS is committing $48 million to expand its cold chain logistics network to handle the surging volume of temperature-sensitive shipments. For health system pharmacy and supply chain teams, this investment signals that third-party logistics costs for cold-chain pharmaceuticals are likely to rise as demand competes for limited refrigerated capacity. If your institution is managing GLP-1 dispensing at scale — inpatient or outpatient — now is the time to review your cold storage contracts and last-mile delivery SLAs.

Source: Yahoo Finance


You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe

Don't miss what's next. Subscribe to My Awesome Newsletter:
← Newer Transparency push, Danaher's Masimo play & 340B reform Older → FedEx Freight eyes healthcare; USPS rate shift July 12
Powered by Buttondown, the easiest way to start and grow your newsletter.